We are live on
!
Find out more
TPG GP A Portfolio holdings
AUM
$5B
Turnover
33.68%
1-Year Est. Return
58.56%
This Fund
S&P 500
This Quarter
Est. Return
-4.29%
1 Year Est. Return
+58.56%
3 Year Est. Return
+100.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.68B
AUM Growth
+$992M
(+37%)
Cap. Flow
+$1.33B
Cap. Flow
% of AUM
36.22%
Top 10 Holdings %
Top 10 Hldgs %
76.38%
Holding
76
New
66
Increased
–
Reduced
3
Closed
–
Avg Time Held
0.4
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jackson Financial
JXN
|
+$527M |
| 2 |
NGL Energy Partners
NGL
|
+$67.4M |
| 3 |
Enviri
NVRI
|
+$67.1M |
| 4 |
Bruker Corporation 6.375% Series A Preferred Stock
BRKRP
|
+$53.2M |
| 5 |
Quanex
NX
|
+$38.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lifestance Health
LFST
|
+$144M |
| 2 |
Sionna Therapeutics
SION
|
+$9.54M |
| 3 |
Rallybio
RLYB
|
+$7 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.79% |
| 2 | Miscellaneous | 18.46% |
| 3 | Financials | 13.63% |
| 4 | Consumer Discretionary | 13.06% |
| 5 | Industrials | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Lifestance Health
LFST
$4.51B
| $892M | 24.25% |
140,026,557
-20,685,061
| -13% | -$144M |
2021 Q4
17 quarters
|
|
|
2
Jackson Financial
JXN
$8.89B
| $499M | 13.55% |
+4,715,554
| New | +$527M |
2026 Q1
0 quarters
|
|
3
Life Time Group Holdings
LTH
$9.1B
| $480M | 13.06% |
17,830,652
| – | – |
2021 Q4
17 quarters
|
|
|
4
Sionna Therapeutics
SION
$175M
| $260M | 7.08% |
6,494,962
-250,000
| -4% | -$9.54M |
2025 Q1
4 quarters
|
|
5
Beta Technologies Inc
BETA
$4.31B
| $241M | 6.55% |
16,395,435
| – | – |
2025 Q4
1 quarter
|
|
6
Amneal Pharmaceuticals
AMRX
$6.64B
| $153M | 4.17% |
12,328,767
| – | – |
2021 Q4
17 quarters
|
|
|
7
NGL Energy Partners
NGL
$1.89B
| $73.2M | 1.99% |
+5,934,493
| New | +$67.4M |
2026 Q1
0 quarters
|
|
8
CeriBell Inc
CBLL
$987M
| $72.7M | 1.98% |
3,967,422
| – | – |
2024 Q4
5 quarters
|
|
|
9
Enviri
NVRI
$552M
| $70.9M | 1.93% |
+3,613,688
| New | +$67.1M |
2026 Q1
0 quarters
|
|
10
Bicara Therapeutics
BCAX
$1.12B
| $59.9M | 1.63% |
3,010,425
| – | – |
2024 Q3
6 quarters
|
|
|
11
Bruker Corporation 6.375% Series A Preferred Stock
BRKRP
$1.13B
| $47M | 1.28% |
+163,000
| New | +$53.2M |
2026 Q1
0 quarters
|
|
12
Allogene Therapeutics
ALLO
$453M
| $45.7M | 1.24% |
18,716,306
| – | – |
2021 Q4
17 quarters
|
|
13
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$4.25B
| $37.3M | 1.01% |
+575,000
| New | +$35.3M |
2026 Q1
0 quarters
|
|
|
14
Quanex
NX
$860M
| $36.9M | 1% |
+2,054,770
| New | +$38.8M |
2026 Q1
0 quarters
|
|
15
Novanta Inc Units
NOVTU
$624M
| $35.4M | 0.96% |
+661,667
| New | +$38.5M |
2026 Q1
0 quarters
|
|
16
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.08B
| $29.3M | 0.8% |
+680,000
| New | +$28.9M |
2026 Q1
0 quarters
|
|
17
NextEra Energy Inc 7.375% Corporate Units
NEE.PRV
| $28.8M | 0.78% |
+575,000
| New | +$28.7M |
2026 Q1
0 quarters
|
|
18
DELISTED
Apollo Global Management Series A
APO.PRA
| $19.1M | 0.52% |
+325,000
| New | +$21.1M |
2026 Q1
0 quarters
|
|
19
PPL Corp Corporate Units
PPLC
| $18.9M | 0.51% |
+370,000
| New | +$18.8M |
2026 Q1
0 quarters
|
|
20
TPG RE Finance Trust
TRTX
$448M
| $18.7M | 0.51% |
2,392,863
| – | – |
2021 Q4
17 quarters
|
|
21
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.11B
| $15.5M | 0.42% |
+419,500
| New | +$18M |
2026 Q1
0 quarters
|
|
22
DELISTED
Electronic Arts
EA
| $13.3M | 0.36% |
+65,000
| New | +$13.1M |
2026 Q1
0 quarters
|
|
23
Norfolk Southern
NSC
$72.8B
| $11.5M | 0.31% |
+40,000
| New | +$11.9M |
2026 Q1
0 quarters
|
|
24
Oracle Corp Preferred Stock Series D
ORCL.PRD
| $10.3M | 0.28% |
+225,000
| New | +$10.6M |
2026 Q1
0 quarters
|
|
25
DELISTED
Clearwater Analytics
CWAN
| $9.11M | 0.25% |
+385,000
| New | +$9.11M |
2026 Q1
0 quarters
|
|
Similar funds
SFM
TPG GP A's Q1 2026 Portfolio in Review
As of Q1 2026, TPG GP A held 76 positions worth $3.68B, up 37% from $2.69B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
TPG GP A deployed $1.33B of net new capital in Q1 2026, opening 66 new positions. Its largest new stake was Jackson Financial: 4,715,554 shares worth $499M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 64% a quarter earlier, followed by Miscellaneous and Financials.
On the sell side, the largest reduction was Lifestance Health, an estimated $144M trimmed.
- TPG GP A's largest Q1 2026 buy was Jackson Financial: 4,715,554 shares worth $499M.
- TPG GP A's biggest Q1 2026 reduction was Lifestance Health, cutting an estimated $144M.
- TPG GP A's ten largest holdings make up 76% of its $3.68B portfolio in Q1 2026.
- TPG GP A opened 66 new positions and closed 0 in Q1 2026.
- TPG GP A's portfolio value rose 37% quarter-over-quarter to $3.68B.
Based on TPG GP A's 13F filing for Q1 2026, filed 15 May 2026.